Suntrust Banks’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,916
| Closed | -$696K | – | 1303 |
|
|
2017
Q2 | $696K | Buy |
11,916
+2,843
| +31% | +$166K | ﹤0.01% | 746 |
|
|
2017
Q1 | $530K | Buy |
9,073
+3,387
| +60% | +$198K | ﹤0.01% | 819 |
|
|
2016
Q4 | $331K | Buy |
5,686
+2,189
| +63% | +$127K | ﹤0.01% | 1214 |
|
|
2016
Q3 | $204K | Buy |
+3,497
| New | +$204K | ﹤0.01% | 1415 |
|
|
2016
Q1 | – | Sell |
-25,924
| Closed | -$1.69M | – | 1506 |
|
|
2015
Q4 | $1.69M | Buy |
25,924
+2,091
| +9% | +$137K | 0.01% | 494 |
|
|
2015
Q3 | $1.5M | Buy |
23,833
+2,445
| +11% | +$154K | 0.01% | 494 |
|
|
2015
Q2 | $1.51M | Buy |
21,388
+4,797
| +29% | +$339K | 0.01% | 491 |
|
|
2015
Q1 | $1.17M | Buy |
16,591
+1,200
| +8% | +$84.3K | 0.01% | 563 |
|
|
2014
Q4 | $989K | Buy |
15,391
+4,098
| +36% | +$263K | 0.01% | 607 |
|
|
2014
Q3 | $717K | Sell |
11,293
-676
| -6% | -$42.9K | 0.01% | 815 |
|
|
2014
Q2 | $741K | Sell |
11,969
-1,638
| -12% | -$101K | 0.01% | 832 |
|
|
2014
Q1 | $793K | Buy |
13,607
+3,149
| +30% | +$184K | ﹤0.01% | 1089 |
|
|
2013
Q4 | $555K | Buy |
10,458
+1,385
| +15% | +$73.5K | ﹤0.01% | 1213 |
|
|
2013
Q3 | $433K | Buy |
9,073
+3,529
| +64% | +$168K | ﹤0.01% | 1298 |
|
|
2013
Q2 | $251K | Buy |
+5,544
| New | +$251K | ﹤0.01% | 1489 |
|